Clinical Trials Browser

Phase 3 × perflutren × 90 days × Clear all

NCT06024772 2025-12-22

Multiparametric Ultrasound for the Diagnosis of Clinically Significant Prostate Cancer

Phase 3 Not yet recruiting

Prostatic Neoplasms